Last reviewed · How we verify

NCT05189626

Effectiveness of Kaltenborn Mobilizations Versus Muscle Energy Technique in Adhesive Capsulitis.

Status unknown NA Last updated 12 January 2022
What this trial tests

NA trial testing Muscle energy technique in Adhesive Capsulitis of Shoulder in 30 participants. Status unknown.

Timeline
6 December 2021
Primary endpoint
31 March 2022
31 March 2022

Quick facts

Lead sponsorHealth Education Research Foundation (HERF)
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date6 December 2021
Primary completion31 March 2022
Estimated completion31 March 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Health Education Research Foundation (HERF)

Who can join

Adults 20 to 60, any sex, with Adhesive Capsulitis of Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Total of 30 patients are selected according to inclusion criteria by convenient sampling and randomly allocated by sealed envelop method into two groups. Group 1 is treated with Muscle energy technique(Post isometric relaxation) and Group 2 is treated with Grade II,III Kaltenborn mobilizations and both groups also receives conventional therapy in form of Codman exercise and Wall ladder exercises.Data will be collected at baseline then after 2 weeks and after 4 weeks of intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Muscle energy technique

Trials testing the same drug.

Other recruiting trials for Adhesive Capsulitis of Shoulder

Currently open trials in the same condition.

Other Health Education Research Foundation (HERF) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05189626.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing